In our earlier study involving individuals with secondary hyperparathyroidism, we observed that active vitamin D reduced levels of both PTH and inflammatory cytokines; additionally, in patients with ESRD, TRACP-5b levels declined following calcitriol treatment and therefore lower the inflammation and oxidative stress [19, 42]. This evidence concerns the gene ACP5 and secondary hyperparathyroidism.